↓ Skip to main content

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation

Overview of attention for article published in Drug Safety, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news
1 news outlet
twitter
7 X users

Citations

dimensions_citation
108 Dimensions

Readers on

mendeley
86 Mendeley
Title
Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation
Published in
Drug Safety, March 2019
DOI 10.1007/s40264-019-00810-9
Pubmed ID
Authors

Lee S. Nguyen, Mathieu Vautier, Yves Allenbach, Noel Zahr, Olivier Benveniste, Christian Funck-Brentano, Joe-Elie Salem

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 86 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 10%
Student > Bachelor 9 10%
Other 8 9%
Student > Doctoral Student 8 9%
Student > Master 6 7%
Other 13 15%
Unknown 33 38%
Readers by discipline Count As %
Medicine and Dentistry 25 29%
Biochemistry, Genetics and Molecular Biology 8 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Immunology and Microbiology 4 5%
Nursing and Health Professions 2 2%
Other 7 8%
Unknown 36 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2023.
All research outputs
#2,570,220
of 23,900,102 outputs
Outputs from Drug Safety
#279
of 1,735 outputs
Outputs of similar age
#58,731
of 354,667 outputs
Outputs of similar age from Drug Safety
#7
of 15 outputs
Altmetric has tracked 23,900,102 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,735 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,667 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.